Center for Scientific Review; Notice of Closed Meetings, 12000-12001 [05-4673]
Download as PDF
<![CDATA[
12000
Federal Register / Vol. 70, No. 46 / Thursday, March 10, 2005 / Notices
and Craniofacial Sciences Special Emphasis
Panel.
Date: April 7, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: J. Terrell Hoffeld, PhD,
DDS, Dental Officer, USPHS, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7816, Bethesda, MD 20892, (301) 435–
1781, hoffeldt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Yeast
Prions.
Date: April 8, 2005.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Richard G. Kostriken, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
MSC 7808, Bethesda, MD 20892, (301) 402–
4454, hostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pain and
Samotosensory (5).
Date: April 8, 2005.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, (301) 435–
2212, josephru@csr.nih.gov.
(Catalogue of Federal Assistance Program
Nos. 93.306, Comparative Medicine; 93.333,
Clinical Research, 93.306, 93.33, 93.337,
93.393–93.396, 93.837–93.844, 93.846–
93.878, 93.892, 93.893, National Institutes of
Health, HHS)
Dated: March 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4672 Filed 3–9–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
VerDate jul<14>2003
18:28 Mar 09, 2005
Jkt 205001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Lung Cancer
Biomarkers.
Date: March 9, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Victor A. Fung, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6178,
MSC 7804, Bethesda, MD 20892, 301–435–
3504, vf6n@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cancer
Diagnostic and Treatment.
Date: March 10–11, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Elaine Sierra-Rivera, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, 301–435–
1779, riverase@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, AMCB
Member Conflicts.
Date: March 21, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1167, srinivar@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel, VACC
Member Conflicts.
Date: March 22, 2005.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ranga V. Srinivas. PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 435–
1167, srinivar@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Regulation
of Melanoma Progression.
Date: March 23, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Zhiqiang Zou, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, zouzhq@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Early
Detection of Lung Cancer.
Date: March 24, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eva Peterakova, PhD MPH,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
1716, petrakoe@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Vitamin D
and Mammary Gland.
Date: March 25, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, (301) 451–
4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Signaling
Pathways and Tumorigenesis.
Date: March 28, 2005.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD,
Scientific Review Administrator, Center for
E:\FR\FM\10MRN1.SGM
10MRN1
12001
Federal Register / Vol. 70, No. 46 / Thursday, March 10, 2005 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, (301) 451–
4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Biomarkers
for Head, Neck and Breast Cancer.
Date: March 31, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Morris I. Kelsey, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, 301–435–
1718, kelseym@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Mental
Development.
Date: March 31, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Karen Lechter, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3128,
MSC 7759, Bethesda, MD 20892, 301–496–
0726, lechterk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1–
EMNR G(02).
Date: April 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Abubakar A. Shaikh, PhD,
DVM, Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 6168, MSC 7892, Bethesda, MD 20892,
301–435–1042, shaikha@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–4673 Filed 3–9–05; 8:45 am]
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
BILLING CODE 4140–01–M
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Substance Abuse
Treatment (CSAT) administers the
Substance Abuse Prevention and
Treatment (SAPT) Block Grant. This is
a major source of funding for substance
abuse activities in 60 jurisdictions,
including all States and Territories. As
part of the SAPT Block Grant, States
with an AIDS case rate of 10 per 100,000
of population are required to set-aside a
portion of SAPT Block Grant funding for
early Human Immunodeficiency Virus
(HIV) intervention. States that qualify
are required to expend 2–5 percent of
their yearly SAPT Block Grant funding
on HIV Early Intervention Services (EIS)
projects.
The purpose of the survey is to assess
the status of HIV Services in substance
abuse treatment systems in the States
and Territories; including how HIV SetAside funds are being utilized, and what
results are being accomplished through
EIS, including counseling, testing, and
treatment, and staff and program
development. A questionnaire will be
sent to the director of each Single State
Authority for the SAPT Block Grant in
the 60 States and Territories, with
responses expected over a two-week
period.
Below is the table of the estimated
total burden hours:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration will publish
periodic summaries of proposed
projects. To request more information
on the proposed projects or to obtain a
copy of the information collection
plans, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
Proposed Project: Survey of Single State
Authorities Regarding the HIV SetAside of the Substance Abuse
Prevention and Treatment Block
Grant—NEW
Respondent
Number of
respondents
Number of
responses
per respondent
Average
burden hour
Estimated
total burden
(hours)
State Manager .................................................................................................................
60
1
1
60
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 71–1045, One Choke Cherry
Road, Rockville, MD 20857. Written
comments should be received within 60
days of this notice.
DEPARTMENT OF HOMELAND
SECURITY
Dated: March 4, 2005.
Patricia S. Bransford,
Acting Executive Officer, SAMHSA.
[FR Doc. 05–4681 Filed 3–9–05; 8:45 am]
Homeland Security Advisory Council;
Correction
BILLING CODE 4162–20–P
ACTION:
VerDate jul<14>2003
18:28 Mar 09, 2005
Office of the Secretary
[DHS–2005–0019]
AGENCY:
Office of the Secretary, DHS.
Notice of correction; notice of
Federal Advisory Committee meeting.
Jkt 205001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
SUMMARY: The Department of Homeland
Security (DHS) is correcting a notice
that was published in the Federal
Register on March 7, 2005, at 70 FR
11017 which announced the holding of
a meeting for the purposes of receiving
reports and briefings, and member
deliberations. In the ADDRESSES section
to the notice, DHS inadvertently omitted
the identification of the appropriate
DHS docket number associated with the
notice. DHS would like to announce
that the DHS docket number for
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 70, Number 46 (Thursday, March 10, 2005)]
[Notices]
[Pages 12000-12001]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4673]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Lung Cancer Biomarkers.
Date: March 9, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Victor A. Fung, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6178, MSC 7804, Bethesda, MD
20892, 301-435-3504, vf6n@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Cancer Diagnostic and Treatment.
Date: March 10-11, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Elaine Sierra-Rivera, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD
20892, 301-435-1779, riverase@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, AMCB Member Conflicts.
Date: March 21, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, 301-435-1167, srinivar@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, VACC Member Conflicts.
Date: March 22, 2005.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ranga V. Srinivas. PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, (301) 435-1167, srinivar@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Regulation of Melanoma Progression.
Date: March 23, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190, MSC 7804, Bethesda, MD
20892, 301-451-0132, zouzhq@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Early Detection of Lung Cancer.
Date: March 24, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eva Peterakova, PhD MPH, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD
20892, 301-435-1716, petrakoe@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Vitamin D and Mammary Gland.
Date: March 25, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD
20892, (301) 451-4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Signaling Pathways and Tumorigenesis.
Date: March 28, 2005.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eun Ah Cho, PhD, Scientific Review
Administrator, Center for
[[Page 12001]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6202, MSC 7804, Bethesda, MD 20892, (301) 451-4467,
choe@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Biomarkers for Head, Neck and Breast Cancer.
Date: March 31, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Morris I. Kelsey, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208, MSC 7804, Bethesda, MD
20892, 301-435-1718, kelseym@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Mental Development.
Date: March 31, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Karen Lechter, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD
20892, 301-496-0726, lechterk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, ZRG1-EMNR G(02).
Date: April 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Abubakar A. Shaikh, PhD, DVM, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6168, MSC 7892, Bethesda, MD
20892, 301-435-1042, shaikha@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-4673 Filed 3-9-05; 8:45 am]
BILLING CODE 4140-01-M
